The Duel
Buzz - deleted

Orioles Get Devastating Chris Davis Injury Update

Adam Taylor McKillop
Chris Davis' injury update is devastating news for the Baltimore Orioles.
Chris Davis' injury update is devastating news for the Baltimore Orioles. / Rob Carr/Getty Images
facebooktwitterreddit

The saga of one of the worst contracts in the MLB took another turn for the worse this past week. Baltimore Orioles slugger Chris Davis' most recent injury update is more devastating news for the Orioles. While the 1B has been sidelined this entire season, the club announced he would undergo surgery on his left hip labrum and miss the remainder of the 2021 season.

From an on-field standpoint, this injury won't really have an effect on the Orioles season. At this point, they've lost all confidence in his ability to perform and are playing the waiting game with his absurd contract.

We all know the story. The Orioles signed Davis in 2016 to a 7-year, $161 million deal after leading the big leagues with 47 home runs the year prior. Since then, Davis own a .196 batting average and has only averaged 18 home runs per year. But, the good news is that next season will be the final year of this insanely bad contract.

Right now, the Orioles are 17-24 overall and own longshot odds of +18000 to win the division, according to FanDuel Sportsbook. This team is still rebuilding and will rejoice once Davis' contract is no longer on the books.


Sign up for FanDuel Sportsbook today and get your first bet risk free for up to $1,000!


Adam Taylor McKillop is not a FanDuel employee. In addition to providing DFS gameplay advice, Adam Taylor also participates in DFS contests on FanDuel using his personal account, username atmckillop. While the strategies and player selections recommended in his articles are his personal views, he may deploy different strategies and player selections when entering contests with his personal account. The views expressed in their articles are the author's alone and do not necessarily reflect the views of FanDuel. 

facebooktwitterreddit